# GE Vernova timeline entity: /record/ge-vernova.md id: ent_ge-vernova GE Vernova's timeline holds 117 claims from 2021 to 2026: 104 money & deals, 13 other. 10 are undated. The latest took effect on September 30, 2026. Kinds: People 0 (/timelines/ge-vernova.md?kind=people) · Money & deals 104 (/timelines/ge-vernova.md?kind=money) · Products 0 (/timelines/ge-vernova.md?kind=products) · Models 0 (/timelines/ge-vernova.md?kind=models) · Other 13 (/timelines/ge-vernova.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2021 - 2021-12-31 to 2022-12-31 | money | total_equity | 13,729,000,000 United States dollar | superseded | [clm_44C7856B6B96](/claim/clm_44C7856B6B96.md) ## 2022 - 2022-06-14 | other | x_username | gevernova | valid | [clm_D4CBD5E23EA5](/claim/clm_D4CBD5E23EA5.md) - 2022-12-31 to 2023-12-31 | money | net_income | -2,736,000,000 United States dollar | superseded | [clm_1CECFC518CC1](/claim/clm_1CECFC518CC1.md) - 2022-12-31 to 2023-12-31 | money | operating_income | -2,881,000,000 United States dollar | superseded | [clm_926C9EF345E6](/claim/clm_926C9EF345E6.md) - 2022-12-31 to 2023-12-31 | money | research_and_development | 979,000,000 United States dollar | superseded | [clm_A9CA6EDFB4B8](/claim/clm_A9CA6EDFB4B8.md) - 2022-12-31 to 2023-12-31 | money | revenue | 29,654,000,000 United States dollar | superseded | [clm_AA31392688E8](/claim/clm_AA31392688E8.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 11,607,000,000 United States dollar | superseded | [clm_95017CA0BAC4](/claim/clm_95017CA0BAC4.md) ## 2023 - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | -315,000,000 United States dollar | superseded | [clm_58F16142D79F](/claim/clm_58F16142D79F.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | -469,000,000 United States dollar | superseded | [clm_7CA4FD1D3400](/claim/clm_7CA4FD1D3400.md) - 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 202,000,000 United States dollar | superseded | [clm_C751BC44C8C4](/claim/clm_C751BC44C8C4.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 6,822,000,000 United States dollar | superseded | [clm_3C65AB3492E8](/claim/clm_3C65AB3492E8.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 10,412,000,000 United States dollar | superseded | [clm_CB793FA4D6A6](/claim/clm_CB793FA4D6A6.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | -150,000,000 United States dollar | superseded | [clm_BD6005C728A0](/claim/clm_BD6005C728A0.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | -341,000,000 United States dollar | superseded | [clm_A865C7F003B8](/claim/clm_A865C7F003B8.md) - 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 216,000,000 United States dollar | superseded | [clm_5421BFAB504C](/claim/clm_5421BFAB504C.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 8,119,000,000 United States dollar | superseded | [clm_63B29017FE26](/claim/clm_63B29017FE26.md) - 2023-06-30 to 2023-09-30 | money | total_equity | 10,802,000,000 United States dollar | superseded | [clm_861D541EA34B](/claim/clm_861D541EA34B.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | -170,000,000 United States dollar | superseded | [clm_34FAACF46862](/claim/clm_34FAACF46862.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | -307,000,000 United States dollar | superseded | [clm_316CEFB5957A](/claim/clm_316CEFB5957A.md) - 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 223,000,000 United States dollar | superseded | [clm_B91F880F087D](/claim/clm_B91F880F087D.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 8,253,000,000 United States dollar | superseded | [clm_341FEDAAD547](/claim/clm_341FEDAAD547.md) - 2023-09-30 to 2023-12-31 | money | total_equity | 10,454,000,000 United States dollar | superseded | [clm_10D855A1325F](/claim/clm_10D855A1325F.md) - 2023-10-27 to 2024-03-13 | other | registrant_name | GE Vernova LLC | superseded | [clm_7ACC2FBE705E](/claim/clm_7ACC2FBE705E.md) - 2023-12-31 to 2024-12-31 | money | net_income | -438,000,000 United States dollar | superseded | [clm_372127FCEE86](/claim/clm_372127FCEE86.md) - 2023-12-31 to 2024-12-31 | money | operating_income | -923,000,000 United States dollar | superseded | [clm_DE66AF1498A0](/claim/clm_DE66AF1498A0.md) - 2023-12-31 to 2024-12-31 | money | research_and_development | 896,000,000 United States dollar | superseded | [clm_A9F0C0EC92E4](/claim/clm_A9F0C0EC92E4.md) - 2023-12-31 to 2024-12-31 | money | revenue | 33,239,000,000 United States dollar | superseded | [clm_8B363468E788](/claim/clm_8B363468E788.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 46,121,000,000 United States dollar | superseded | [clm_1BE39ECAA3CB](/claim/clm_1BE39ECAA3CB.md) - 2023-12-31 to 2024-03-31 | money | total_equity | 7,416,000,000 United States dollar | superseded | [clm_E3F466CC5566](/claim/clm_E3F466CC5566.md) ## 2024 - 2024-03-13 | other | registrant_name | GE Vernova Inc. | valid | [clm_94D5839C334D](/claim/clm_94D5839C334D.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | -130,000,000 United States dollar | superseded | [clm_46EADA045236](/claim/clm_46EADA045236.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | -289,000,000 United States dollar | superseded | [clm_80D99D8DD563](/claim/clm_80D99D8DD563.md) - 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 237,000,000 United States dollar | superseded | [clm_575EE98C4C8C](/claim/clm_575EE98C4C8C.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 7,260,000,000 United States dollar | superseded | [clm_D85D65F0B650](/claim/clm_D85D65F0B650.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 47,872,000,000 United States dollar | superseded | [clm_99D43D4763C8](/claim/clm_99D43D4763C8.md) - 2024-03-31 to 2024-06-30 | money | total_equity | 8,974,000,000 United States dollar | superseded | [clm_62F99E62000E](/claim/clm_62F99E62000E.md) - 2024-04-26 to 2024-07-17 | money | shares_outstanding | 274,085,523 shares | superseded | [clm_EF94A83AD968](/claim/clm_EF94A83AD968.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 1,294,000,000 United States dollar | superseded | [clm_9F7C4F392D55](/claim/clm_9F7C4F392D55.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 527,000,000 United States dollar | superseded | [clm_6294FBA1D56A](/claim/clm_6294FBA1D56A.md) - 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 237,000,000 United States dollar | superseded | [clm_4121BA46A118](/claim/clm_4121BA46A118.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 8,204,000,000 United States dollar | superseded | [clm_D599E32BD904](/claim/clm_D599E32BD904.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 48,052,000,000 United States dollar | superseded | [clm_F0B4D6A5C7E1](/claim/clm_F0B4D6A5C7E1.md) - 2024-06-30 to 2024-09-30 | money | total_equity | 9,067,000,000 United States dollar | superseded | [clm_D5C4437B9DF1](/claim/clm_D5C4437B9DF1.md) - 2024-07-17 to 2024-10-16 | money | shares_outstanding | 274,802,034 shares | superseded | [clm_6F788B818FCE](/claim/clm_6F788B818FCE.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | -96,000,000 United States dollar | superseded | [clm_81C72E740552](/claim/clm_81C72E740552.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | -359,000,000 United States dollar | superseded | [clm_A77A72A82BCB](/claim/clm_A77A72A82BCB.md) - 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 243,000,000 United States dollar | superseded | [clm_1440A0D94A7D](/claim/clm_1440A0D94A7D.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 8,913,000,000 United States dollar | superseded | [clm_B788B9602083](/claim/clm_B788B9602083.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 50,853,000,000 United States dollar | superseded | [clm_E4FEFBB507EA](/claim/clm_E4FEFBB507EA.md) - 2024-09-30 to 2024-12-31 | money | total_equity | 9,504,000,000 United States dollar | superseded | [clm_6E7F1D5E06E8](/claim/clm_6E7F1D5E06E8.md) - 2024-10-16 to 2025-01-15 | money | shares_outstanding | 275,652,970 shares | superseded | [clm_21D260EA3D3D](/claim/clm_21D260EA3D3D.md) - 2024-12-31 to 2025-12-31 | money | net_income | 1,552,000,000 United States dollar | superseded | [clm_4716F510B946](/claim/clm_4716F510B946.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 471,000,000 United States dollar | superseded | [clm_DAC7E480D648](/claim/clm_DAC7E480D648.md) - 2024-12-31 to 2025-12-31 | money | research_and_development | 982,000,000 United States dollar | superseded | [clm_73D7296D58DD](/claim/clm_73D7296D58DD.md) - 2024-12-31 to 2025-12-31 | money | revenue | 34,935,000,000 United States dollar | superseded | [clm_5433EC24F78B](/claim/clm_5433EC24F78B.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 51,485,000,000 United States dollar | superseded | [clm_C3E19D25B0EA](/claim/clm_C3E19D25B0EA.md) - 2024-12-31 to 2025-03-31 | money | total_equity | 9,546,000,000 United States dollar | superseded | [clm_1915924B4602](/claim/clm_1915924B4602.md) ## 2025 - 2025-01-15 to 2025-03-31 | money | shares_outstanding | 275,900,754 shares | superseded | [clm_3DABCBC35C2B](/claim/clm_3DABCBC35C2B.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 254,000,000 United States dollar | superseded | [clm_5FA6DD1FBA8A](/claim/clm_5FA6DD1FBA8A.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 43,000,000 United States dollar | superseded | [clm_43E23F2DF509](/claim/clm_43E23F2DF509.md) - 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 239,000,000 United States dollar | superseded | [clm_29B7DDDDD791](/claim/clm_29B7DDDDD791.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 8,032,000,000 United States dollar | superseded | [clm_06259E9CB8D1](/claim/clm_06259E9CB8D1.md) - 2025-03-31 to 2025-06-30 | money | shares_outstanding | 272,934,744 shares | superseded | [clm_BAAB6A52155A](/claim/clm_BAAB6A52155A.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 51,559,000,000 United States dollar | superseded | [clm_2BAB18688055](/claim/clm_2BAB18688055.md) - 2025-03-31 to 2025-06-30 | money | total_equity | 8,607,000,000 United States dollar | superseded | [clm_C67658760C77](/claim/clm_C67658760C77.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 514,000,000 United States dollar | superseded | [clm_149EBD658AA8](/claim/clm_149EBD658AA8.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 378,000,000 United States dollar | superseded | [clm_3713539BC7A5](/claim/clm_3713539BC7A5.md) - 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 282,000,000 United States dollar | superseded | [clm_65815606F09C](/claim/clm_65815606F09C.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 9,111,000,000 United States dollar | superseded | [clm_209A0DDA23CB](/claim/clm_209A0DDA23CB.md) - 2025-06-30 to 2025-09-30 | money | shares_outstanding | 272,223,940 shares | superseded | [clm_DF9CDE020EBA](/claim/clm_DF9CDE020EBA.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 53,078,000,000 United States dollar | superseded | [clm_E7513B72755A](/claim/clm_E7513B72755A.md) - 2025-06-30 to 2025-09-30 | money | total_equity | 8,877,000,000 United States dollar | superseded | [clm_3AC532EAF13C](/claim/clm_3AC532EAF13C.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 452,000,000 United States dollar | superseded | [clm_1657892C7E2C](/claim/clm_1657892C7E2C.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 366,000,000 United States dollar | superseded | [clm_04F2B25B54A9](/claim/clm_04F2B25B54A9.md) - 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 310,000,000 United States dollar | superseded | [clm_63A64ACDDAFC](/claim/clm_63A64ACDDAFC.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 9,969,000,000 United States dollar | superseded | [clm_9689EDA15790](/claim/clm_9689EDA15790.md) - 2025-09-30 to 2025-12-31 | money | shares_outstanding | 271,320,459 shares | superseded | [clm_F802C3507847](/claim/clm_F802C3507847.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 54,398,000,000 United States dollar | superseded | [clm_EB7E2EA9668E](/claim/clm_EB7E2EA9668E.md) - 2025-09-30 to 2025-12-31 | money | total_equity | 8,646,000,000 United States dollar | superseded | [clm_420B19725E5F](/claim/clm_420B19725E5F.md) - 2025-12-31 | money | net_income | 4,884,000,000 United States dollar | valid | [clm_E288F73CD7E4](/claim/clm_E288F73CD7E4.md) - 2025-12-31 | money | operating_income | 1,388,000,000 United States dollar | valid | [clm_14D6B6B8F277](/claim/clm_14D6B6B8F277.md) - 2025-12-31 | money | research_and_development | 1,197,000,000 United States dollar | valid | [clm_FD234D855208](/claim/clm_FD234D855208.md) - 2025-12-31 | money | revenue | 38,068,000,000 United States dollar | valid | [clm_A671C45E0B36](/claim/clm_A671C45E0B36.md) - 2025-12-31 to 2026-03-31 | money | shares_outstanding | 269,529,464 shares | superseded | [clm_4EAC81B2A9EA](/claim/clm_4EAC81B2A9EA.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 63,016,000,000 United States dollar | superseded | [clm_E526FA6A2A45](/claim/clm_E526FA6A2A45.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 11,178,000,000 United States dollar | superseded | [clm_4EE9FA87653F](/claim/clm_4EE9FA87653F.md) ## 2026 - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 4,745,000,000 United States dollar | superseded | [clm_AA33CBE17B7C](/claim/clm_AA33CBE17B7C.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 179,000,000 United States dollar | superseded | [clm_BFAC2CF1E18A](/claim/clm_BFAC2CF1E18A.md) - 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 304,000,000 United States dollar | superseded | [clm_806AB5A61A68](/claim/clm_806AB5A61A68.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 9,339,000,000 United States dollar | superseded | [clm_8DC52DBBF891](/claim/clm_8DC52DBBF891.md) - 2026-03-31 to 2026-06-30 | money | shares_outstanding | 268,719,995 shares | superseded | [clm_5B30362BCB79](/claim/clm_5B30362BCB79.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 75,612,000,000 United States dollar | superseded | [clm_BBD335D7C3EA](/claim/clm_BBD335D7C3EA.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 13,922,000,000 United States dollar | superseded | [clm_082E3C6E7A36](/claim/clm_082E3C6E7A36.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 668,000,000 United States dollar | superseded | [clm_8903C487CAD8](/claim/clm_8903C487CAD8.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 653,000,000 United States dollar | superseded | [clm_99D9669636D3](/claim/clm_99D9669636D3.md) - 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 334,000,000 United States dollar | superseded | [clm_048685FCB0D6](/claim/clm_048685FCB0D6.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 11,104,000,000 United States dollar | superseded | [clm_DF3095AFE43D](/claim/clm_DF3095AFE43D.md) - 2026-06-30 to 2026-09-30 | money | shares_outstanding | 266,333,581 shares | superseded | [clm_65D32A819D66](/claim/clm_65D32A819D66.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 80,800,000,000 United States dollar | superseded | [clm_CE41D5595E58](/claim/clm_CE41D5595E58.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 11,957,000,000 United States dollar | superseded | [clm_73BC2113166E](/claim/clm_73BC2113166E.md) - 2026-09-30 | money | quarterly_net_income | 1,291,000,000 United States dollar | valid | [clm_A0F040005791](/claim/clm_A0F040005791.md) - 2026-09-30 | money | quarterly_operating_income | 1,394,000,000 United States dollar | valid | [clm_F03B0702BE11](/claim/clm_F03B0702BE11.md) - 2026-09-30 | money | quarterly_research_and_development | 358,000,000 United States dollar | valid | [clm_0C743AEA4345](/claim/clm_0C743AEA4345.md) - 2026-09-30 | money | quarterly_revenue | 12,642,000,000 United States dollar | valid | [clm_C8E70633038C](/claim/clm_C8E70633038C.md) - 2026-09-30 | money | shares_outstanding | 264,677,066 shares | valid | [clm_20589E04D65A](/claim/clm_20589E04D65A.md) - 2026-09-30 | money | total_assets | 86,220,000,000 United States dollar | valid | [clm_AE9BC831A0EE](/claim/clm_AE9BC831A0EE.md) - 2026-09-30 | money | total_equity | 11,382,000,000 United States dollar | valid | [clm_425584DA7A87](/claim/clm_425584DA7A87.md) ## undated - undated | other | cik | 0001996810 | valid | [clm_43780485C741](/claim/clm_43780485C741.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_5B359EBD14E7](/claim/clm_5B359EBD14E7.md) - undated | other | headquarters | Cambridge | valid | [clm_AEFDCDA8C13F](/claim/clm_AEFDCDA8C13F.md) - undated | other | listed_on | NYSE | valid | [clm_A6947410ED48](/claim/clm_A6947410ED48.md) - undated | other | sic_industry | Electronic & Other Electrical Equipment (No Computer Equip) (3600) | valid | [clm_6C86603CB462](/claim/clm_6C86603CB462.md) - undated | other | state_of_incorporation | DE | valid | [clm_6116EC9F61A6](/claim/clm_6116EC9F61A6.md) - undated | other | ticker | GEV | valid | [clm_CD9D7F134773](/claim/clm_CD9D7F134773.md) - undated | other | linkedin | gevernova | valid | [clm_6EC0D9E7CE6E](/claim/clm_6EC0D9E7CE6E.md) - undated | other | website | https://www.gevernova.com/ | unverified | [clm_883D5D85A31B](/claim/clm_883D5D85A31B.md) - undated | other | website | https://www.gevernova.com | unverified | [clm_B3BF2A8A8694](/claim/clm_B3BF2A8A8694.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.